Train of thought on the application of molecular biology technology in new drug development of traditional Chinese medicine

Abstract

CLC Number:

R284
R966

CHEN Qiu, XIA Yong-Peng, QIU Zong-Yin. Train of thought on the application of molecular biology technology in new drug development of traditional Chinese medicine[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 601-603.

References

1 刘建勋,丛伟红.我国植物药(中药)研究的问题与建议[J].中国中药杂志,2002;27:484-6
2 杨焕明.基因组学——— 中医现代化的一个切入点[C].中医学与基因组学术会,1991
3 宋为民,王艳,徐力,等.基因组学是中医现代化的最佳切入点[J].南京中医学院学报,1999;15:193-5
4 Sato A,Shimomura K,Yamazaki M,et al.Genetic relationshiPamong glycyrrhiziaPlants determined by RAPD analysis[J].BiolPharm Bull,1994;77:1529-35
5 ShirotaO,Watanabe A,YamazakiM,et al.Random amplifiedPolymorphic DNA and restriction fragmentlengthPolymorphism analyses of cannabis sativa[J].Natural Medicine,1998;52:160-4
6 张荣.用RAPD 分析法鉴定木蓝属生药[J].中国中药杂志,1997;22:72-4
7 Cao H,ButPPH,ShawPC.A Molecular approach to identification of the Chinese drugPu Gong Ying(herba taraxaci)and six adulterants by DNA fingerprinting using randomPrimedPolymerase chain reaction(PCR)[J].J ChinPharm Sci,1996;5:186-91
8 Yang GP,Ross DT,Kuang WW,et al.Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes[J].Nucleic Acide Res,1999;27:1517-22
9 王升启.基因芯片技术及应用研究进展[J].生物工程进展,1999;19:45-7
10 Rosea AD.Genome-basedPharmacogenetics and thePharmaceutical industry [J].Nat Rev Drug Discov,2002;1:541-5
11 徐砚通,王钊.后基因组时代的中药现代化研究[J].中国中医基础医学杂志,2001;7:18-21
12 吴志奎,蔡辉国,姜葆华.中药“ 补肾生血胶囊” 治疗β-地中海贫血分子机理的研究[J].国际中医遗传学与中医心理学论丛,1998;10:11-2
13 Miqu Wang.Experimental study of B ehavioral genetics for congenital kidney deficiency [J].Sciences of TCM(USA),1997;3:6-11
14 罗非群,曹亚.基因芯片技术的出现及对生命科学发展的影响[J].医学与哲学,1999;20:35-7
15 陈亚利,陆祖宏.生命科学领域的新工具——— 基因芯片[J].男性学报,1999;4:103-5

[1]	YOU Rongli, HUANG Yurong, MAORui, HAI Lina, WANG Yingli, WANG Yan. Mechanism of compound kushen injection in the treatment of lung cancer based on serum metabolomics and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 988-999.
[2]	WANG Lin, YU Jianguo, LI Xiao, LUAN Jiajie. Establish and implement a pre-prescription system for outpatient based on Six Sigma DMAIC model [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 780-787.
[3]	HU Kangyi, CAO Linzhong, WAN Chaochao, SHANG Zhengya, YANG Xiaorui, ZHANG Yongjie. Research progress of traditional Chinese medicine regulating mitochondrial function in the treatment of steroid-induced femoral head necrosis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 688-696.
[4]	CAO Fang, QIN Kairong, ZHENG Guoshuang, ZHAO Dewei. Exploring the intervention mechanism of Ginkgo biloba for steroid-induced necrosis of the femoral head based on network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 266-275.
[5]	MA Guangli, ZHANG Jing. Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
[6]	HOU Xiaoyu, LENG Yufang, CAO Xuefen, LV Xingjiao, HAN Xiaoxia, Janvier NIBARUTA, LIU Yongqiang. Network analysis and experimental verification of Schisandrin B reduces intestinal ischemia reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 147-154.
[7]	LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang. Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282.
[8]	CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
[9]	GAO Lili, WANG Yuzhu, WANG Yan, LI Jian, WANG Jun. General considerations for clinical pharmacology of antitumor antibody-conjugated drugs: Implications from FDA review cases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 75-85.
[10]	LIU Yanzhi, WANG Yan, LIU Kaili, ZHOU Wenhua, ZHU Ping, WANG Yingli, DU Shouying. Inhibition and mechanism of Xihuang pill on mice bearing hepatoma H22 tumor [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 754-761.
[11]	YAO Qian, CHEN Yun, SHANG Juan, XI Xiaoyun, CHEN Ying, GU Xiao, JU Wenzheng, ZOU Jiandong, LU Su, XU Meijuan. Investigation of potential pharmacodynamic substances and mechanism of Qingxin-zishen prescription decoction in treatment of menopause syndrome based on HPLC-Q-TOF-MS/MS and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 481-497.
[12]	ZHANG Ningzhi, ZHAO Yuhong, TANG Minna, ZHANG Yongqiao, NING Sisi, CUI Zhaoqiang. Application of chronopharmacology in the hypertension treatment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 418-422.
[13]	XIE Mengdie, WANG Chenchen, LI Bingtao, OUYANG Changsheng, QIU Yumei, LI Hongming, TU Jun, SHANG Guangbin, TANG Xilan. Analysis on mechanism of frankincense volatile oil in prevention and treatment of cardiac hypertrophy based on in vitro cell experiment and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 241-252.
[14]	CHEN Yugang, TU Yanqiong, WANG Congqing, CHEN Juan, ZHANG Bohong. Network pharmacology and molecular docking to discuss the mechanism of Jinhutongdan prescription in the treatment of cholelithiasis and experimental verification [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1090-1098.
[15]	SHE Zhihua, CHEN Zhou, LIANG Songyue. Construction of informatization system of drug clinical trials ethical review based on cloud architecture [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1023-1030.